KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $835.9 million.

  • Emergent BioSolutions' Total Non-Current Liabilities fell 1046.49% to $835.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $835.9 million, marking a year-over-year decrease of 1046.49%. This contributed to the annual value of $867.8 million for FY2024, which is 2420.96% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Total Non-Current Liabilities of $835.9 million as of Q3 2025, which was down 1046.49% from $841.4 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Total Non-Current Liabilities high stood at $1.7 billion for Q4 2022, and its period low was $835.9 million during Q3 2025.
  • Over the past 5 years, Emergent BioSolutions' median Total Non-Current Liabilities value was $1.2 billion (recorded in 2022), while the average stood at $1.2 billion.
  • Per our database at Business Quant, Emergent BioSolutions' Total Non-Current Liabilities surged by 4908.29% in 2023 and then tumbled by 3548.26% in 2024.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Total Non-Current Liabilities stood at $1.3 billion in 2021, then soared by 36.06% to $1.7 billion in 2022, then plummeted by 34.09% to $1.1 billion in 2023, then dropped by 24.21% to $867.8 million in 2024, then decreased by 3.68% to $835.9 million in 2025.
  • Its Total Non-Current Liabilities stands at $835.9 million for Q3 2025, versus $841.4 million for Q2 2025 and $838.0 million for Q1 2025.